PSI is a non-profit organisation formed in 1977 which provides a forum for regular discussion of statistics and issues relating to the practice of statistics in the pharmaceutical industry, as well as promoting good statistical practice within the industry.

Why join PSI


We provide...

opportunities for our members to network, develop themselves and shape the industry

We are...

run by our membership through a network of committees and special interest groups

We promote...

best statistical practice to our members and promote the value of statistics to the external world

Statisticians in the Pharmaceutical Industry
Executive Office: Durford Mill, Petersfield, Hampshire, GU31 5AZ e: PSI@MCI-group.com t: +44 (0)1730 715 235 

Latest News


Show all news

EventsFuture Events


  • EFSPI/PSI Webinar: Do you understand the patient point of view on benefit-risk tradeoffs? Introduction and case studies of stated preference elicitation methods - Dates: 20 – 20 Nov, 2018

    This webinar proposes a short primer on stated preference methods and how they can be used to explore the patient preferences for specific drug profiles that are currently available or may be developed in the near future. The theory will be then discussed as applied to two case studies using quantitative preference methods.
  • Introduction to R & Regression Models in R - Dates: 21 Nov, 2018

  • One Day Course: Practicalities in designing, grant funding, setting up and running a Continual Reassessment Method (CRM) dose finding phase I trial - Dates: 28 – 28 Nov, 2018

    In this one day course you will learn about the practicalities of running a phase I dose-finding Continual Reassessment Method (CRM) trial. During the day we will introduce the CRM design, run a CRM trial, provide training on the features in designing a CRM, move onto ideas in making a grant application, then planning in set-up and running of a CRM trial.
  • PSI Webinar: Avoiding Pitfalls in Supervised/Unsupervised Learning - Dates: 29 – 29 Nov, 2018

    As the availability of big data increases and statisticians assist with predicting outcomes or understanding patterns in an ever-wider variety of scenarios then supervised and unsupervised learning methods become increasing called upon. Such machine learning algorithms offer the opportunity to understand potential predictors or clusters amongst large datasets, but are also subject to the risks of overfitting or over-interpretation. This Webinar seeks to introduce ideas and share experiences in this field.
  • Multilevel Modelling - Dates: 06 Dec, 2018

  • Advanced Programming in R - Dates: 11 Dec, 2018

  • PSI and DIA Journal Club: Statistical Considerations for Innovative Designs in Clinical Trials - Dates: 11 – 11 Dec, 2018

    Our next journal club, held jointly with the DIA, features two papers on the topic of Statistical Considerations for Innovative Designs in Clinical Trials. Please join us to hear Jason Yuan and Xiangmin Zhang present their recent work.
  • Decision-making in drug development - Dates: 12 Dec, 2018

    This meeting aims to bring together statisticians from the pharmaceutical industry and academia to hear about recent advances in statistical methods for quantitative decision-making in drug development.
  • PSI Webinar: How to use prior knowledge and still give new data a chance? - Dates: 19 – 19 Dec, 2018

    The paper to be presented appeared earlier this year in Pharmaceutical Statistics (Weber, Hemmings, Koch, 17, 329-341) and is motivated by the opportunities and challenges for using Bayesian methods with informative priors to support drug development and licencing when only a small pool of patients is available, as in the case of rare diseases and paediatric population.
  • PSI Webinar: HTA Submissions in the UK - Dates: 21 – 21 Jan, 2019

    There is a simple equation for access in the UK: Access = Reimbursement + Uptake. Yet, whilst a simple and logical approach, each component is challenging to achieve. This webinar focuses on the National Reimbursement side: the National Institute for Health and Care Excellence (NICE) - who they are, what is involved in the Health Technology Appraisal (HTA) assessment, how they make decisions.
  • PSI One Day Meeting: New Emerging Topics around Estimands and ICH Addendum - Dates: 29 Jan, 2019

    The draft ICH E9 addendum on estimands and sensitivity analysis was released back in July 2017 and (more than 1000) comments are back. All stakeholders are gaining the necessary experience and familiarity with estimands along with the associated challenges and methodologies. The language and thinking behind causal inference is well suited to this area.
  • Medical Statistics Careers Event 2019 - Dates: 20 Feb, 2019

    Our annual PSI Medical Statistics Careers Event, will be held at the De Montfort University in Leicester on Wednesday 20th February 2019.
  • PSI Conference 2019 - Dates: 02 – 05 Jun, 2019

    PSI are pleased to announce that the countdown to the 2019 Conference has begun! The theme for the conference is “Data Driven Decision Making in Medical Research”. The 2019 PSI Conference will take place at the Queen Elizabeth II Centre (QEII), London, from 2nd to 5th June 2019.
  • Introduction To Industry Training Course 2019 - Dates: 01 Oct, 2019

    The ITIT course will take 25 delegates new to the industry on a complete drug development experience from discovery to marketing. They will visit 6 companies from October 2019 to July 2020 to learn about 6 topics from experts in their field. The ITIT course will have 3 sessions in continental Europe and 3 sessions in the UK. It promises to be a truly memorable course.